<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">Since HIV-1 variability can impact transmission, pathogenesis and disease progression
 <sup>
  <xref ref-type="bibr" rid="CR13">13</xref>â€“
  <xref ref-type="bibr" rid="CR15">15</xref>
 </sup>, HIV monitoring
 <sup>
  <xref ref-type="bibr" rid="CR16">16</xref>,
  <xref ref-type="bibr" rid="CR17">17</xref>
 </sup>, resistance pathways
 <sup>
  <xref ref-type="bibr" rid="CR18">18</xref>
 </sup>, cognitive impairment
 <sup>
  <xref ref-type="bibr" rid="CR19">19</xref>
 </sup>, and HIV vaccine development
 <sup>
  <xref ref-type="bibr" rid="CR20">20</xref>
 </sup>, an accurate HIV-1 variant identification is needed
 <sup>
  <xref ref-type="bibr" rid="CR21">21</xref>
 </sup>. It can enable a better understanding of global HIV expansion
 <sup>
  <xref ref-type="bibr" rid="CR22">22</xref>,
  <xref ref-type="bibr" rid="CR23">23</xref>
 </sup> and to infer the evolutionary possibilities in the selection of new variants, such as the recently described subtype L
 <sup>
  <xref ref-type="bibr" rid="CR10">10</xref>
 </sup>. HIV-1 molecular surveillance studies are globally important and of interest in any setting. However, it is more interesting to analyze HIV molecular diversity in an area with a high viral diversity, especially if the place is the origin of a HIV-1 pandemic, where the virus has been circulating for a longer period and new, more pathogenic or transmissible variants could have arised. HIV-1 pandemic originated in Central Africa
 <sup>
  <xref ref-type="bibr" rid="CR24">24</xref>
 </sup>, specifically in the DRC, Kinshasa being the epicenter
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>
 </sup>, spreading to neighboring cities or countries
 <sup>
  <xref ref-type="bibr" rid="CR25">25</xref>
 </sup>.
</p>
